Altair Nanotechnologies Inc., a Reno, Nev., supplier of advanced ceramic nanomaterial technology, announced that the US Patent Office has allowed Altair's patent application describing the process and underlying technology for producing nano-size and submicron-size oxides of lithium and a transition metal with particle size over a range of 10 to 1,000 nanometers and with narrow size dispersion. The patent was derived from developing cathode materials for next-generation lithium ion batteries and complements a patent announced by Altair in January relating to materials for anodes. . . . Light Sciences Corp., developer of light-infusion technology (Litx), has created three new subsidiaries: Light Sciences Oncology Inc., Visient Therapeutics Inc. and Vascular Reconditioning Inc. The spinoff companies will develop light-activated treatments using Litx, a photodynamic therapy platform in which the photoreactive drug LS11 (talaporfin sodium) is activated by light from an LED-based light infusion device to treat diseases such as macular degeneration and atherosclerosis. The companies will have exclusive access to Light Sciences' intellectual property and will individually seek venture funding.
MORE FROM PHOTONICS MEDIA